Source: Manhattan Corporation
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Manhattan Corporation (MHC) is continuing to intersect high-grade gold mineralisation at the Tibooburra Gold Project in northwest NSW
  • A total of 14 reverse circulation holes and one diamond precollar were drilled at the New Bendigo Main Zone to target additional mineralisation and the north-plunging shoots
  • The drilling has continued to successfully intersect significant shallow gold mineralisation with grades peaking at 10.3g/t gold
  • Manhattan expects to continue RC drilling until mid-2022 after which it will undertake a diamond drilling program
  • Shares in Manhattan are up 7.14 per cent on the market and are trading at 1.5 cents

Manhattan Corporation (MHC) is continuing to intersect high-grade gold mineralisation at the Tibooburra Gold Project in northwest NSW.

The 2200-square-kilometre Tibooburra Project covers a roughly 220-kilometre strike of significantly underexplored gold mineralisation.

A total of 14 reverse circulation (RC) holes and one diamond precollar were drilled, for a total of 1795 metres, at the New Bendigo Main Zone to target additional mineralisation and the north-plunging shoots along the zone.

The drilling has continued to successfully intersect significant shallow gold mineralisation often from or near surface.

Significant results so far include 63 metres at 1.33 grams of gold per tonne (g/t) from 24 metres including nine metres at 7.22g/t gold from 56 metres and one metre at 10.3g/t gold from 76 metres.

Manhattan expects to continue RC drilling until mid-2022 after which it will undertake a diamond drilling program.

The company will continue to test the extents of the Main Zone mineralised system which has the potential to host a significant shallow, high-grade gold resource.

Shares in Manhattan were up 7.14 per cent on the market and were trading at 1.5 cents at 11:16 am AEDT.

mhc by the numbers
More From The Market Online
Hong Kong coastline drone shot

Paradigm Biopharma activates Hong Kong trial site for Phase III osteo trial for iPPS

Paradigm Biopharmaceuticals (ASX:PAR) has kicked off the screening process for participants with osteoarthritis ahead of the company’s Hong Kong-based
A HotCopper-branded graphic image which reads "The HotList Top 10: This week's most watchlisted ASX stocks" in front of an ASX chart image faded in the background.

HotList stocks: Northern Star, Immutep, Lodestar, and other trending companies in Week 12

Good afternoon, and welcome to the HotCopper HotList column.

Juno identifies early promise at Mount Ida gold anomaly

Juno Minerals has obtained promising results from drilling of a significant gold anomaly at the Mt…

Basin Energy receives government funding to fast-track Sybella-Barkly REE studies

Basin Energy has landed two separate funding packages to advance its Sybella-Barkly project in Queensland.